All posts by imreal

Science: Biology

Leak Detection Associates to Serve as Technical Presenter at PDA Europe CCIT Training Course

Leave a comment


Leak Detection Associates at PDF Europe - Helium Leak Detection

We are extremely excited to be part of this highly educational event to specifically represent a key test method for container and package integrity testing specific to USP 1207 requirements


LITTLE EGG HARBOR, N.J. (PRWEB)

Leak Detection Associates, the leading global supplier of helium based leak detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce that it will be a contributing instrument manufacturer and technical presenter at the Parenteral Drug Association (PDA) Container Closure Integrity Testing Basic Training Course. Held in conjunction with PDA Europe’s 10th Parenteral Packaging Conference, the two-day training program encompasses presentations on theory and real-life applications of all deterministic container closure integrity test (CCIT) technologies referenced in USP 1207. Critically, participating attendees are given the opportunity to witness demonstrations of actual instrumentation, with the unique opportunity for hands-on use in an engaging and learning-based environment.

The PDA 10th Parenteral Packaging Conference will be held in Basel, Switzerland on February 25th & 26th and the CCI specific training course is scheduled to follow on February 26th & 27th. Presenting on behalf of Leak Detection Associates will be Brian Mulhall, CEO and former Founder/President of Whitehouse Analytical Laboratories, while Jeff Morrow Lucas, LDA’s Director of Engineering, will host the hands-on technical training for attendees. In support of these technical presentations and hands-on activities, Leak Detection Associates will be providing its newest model, the SIMS 1915+ Helium Leak Detection System. Attendees will gain an understanding of how the system can be used to establish inherent integrity, optimize manufacturing, and more for a range of package systems and at extreme levels of sensitivity. LDA will also be featuring its new, low temperature add-on system that enables analysis of packages down to -80°C, critical for product-packages stored at these aggressive temperatures.

“We are extremely excited to be part of this highly educational event to specifically represent a key test method for container and package integrity testing specific to USP 1207 requirements,” commented Brian Mulhall, LDA’s CEO. “For more than 20 years, Leak Detection Associates has held a leadership role in the development and use of helium technology for container leak testing and having the opportunity to advance our knowledge and experience as part of a unique training seminar such as this will enable the value of helium leak testing to be shared with many relevant participants who are looking for CCI solutions in this highly regulated area.”

This course focuses on theoretical and practical fundamentals of various CCI testing technologies and provides a systematic approach to apply these testing methods for CCI verification throughout drug product lifecycles. The course, as a whole, will enable the participants to implement CCI testing strategies to ensure adequate drug product protection and be compliant with relevant regulatory and compendial requirements. In this course, participants gain critical problem-solving skills through:


  •     Interactive discussions with a panel of cross-functional technical experts consisting of CCI testing laboratory experts, testing instrument suppliers/manufacturers, and pharmaceutical packaging development engineers

  •     Hands-on testing training on the newest innovations and state-of-the-art instruments

  •     Real-world case studies

Being held in conjunction with the 10th Parenteral Packaging Conference, this training course will utilize lectures, case studies, and interactive hands-on training on testing instruments to provide insight into the latest developments of Container Closure Integrity (CCI) Testing. It is expected that participants will develop an understanding of the most up-to-date regulatory and pharmacopeia requirements on CCIT while learning how to define CCI requirements for various container and drug product types using a risk-based approach. The key focus will be on practical applications using the deterministic methods such as tracer gas detection (e.g. helium leak detection), electrical conductivity and capacitance (HVLD), vacuum decay leak detection, laser-based gas headspace analysis, and mass extraction leak tests. Other key topic areas to be covered include selecting and applying appropriate testing methods for both laboratory and in-process testing to formulate comprehensive package integrity verification profiles, defining CCI testing method development and validation approaches and best practices, and avoiding common issues and pitfalls in CCI testing applications. To learn more about the conference and to register for attendance at this valuable training course, please visit http://www.pda.org.

About Leak Detection Associates, LLC

For over 20 years, Leak Detection Associates has been the premier manufacturer of custom helium leak detection instruments for the pharmaceutical, biotechnology, medical device and food packaging industries. LDA’s well-established technology has been incorporated into ASTM and compendial guidance documents. This robust industry experience, combined with the advanced capabilities of its newest model, the SIMS 1915+ helium leak detection unit, provides companies with tools to quantitatively evaluate leakage, improve the package development cycle, establish manufacturing controls, and ultimately reduce risk to the product and consumer throughout the lifecycle.

Share article on social media or email:

Society: Christianity

The Return to Hidden Forest” is a stirring narrative of a group of friends that shows how to embrace change

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“Inheritance of the Meek: The Return to Hidden Forest”: an enthralling book that inspires the readers to be brave in embracing renewal. “Inheritance of the Meek: The Return to Hidden Forest” is the creation of published author Ronald R. Strahl, an educator and counselor who has dedicated his career to helping individuals discover solutions for the many painful dilemmas that their lives present.

Strahl writes, “Inheritance of the Meek: The Return to Hidden Forest is a fast-paced and heartwarming story about how a group of friends discovers the importance of questioning old beliefs and of embracing renewal. The friends have some innocent misadventures with a family of bears that help them understand how their wild cousins don’t spend time mired in the past. By contrast, they learn that when human encounters went sour it was usually a product of lazy humans holding on to old beliefs and behaviors that had lost most of their original meaning.

“This book features Chase Baer, who demonstrates both strength and willingness to embrace change. From surviving a plot to get him fired to finding the love of his life, Chase Baer demonstrates an example after example of the kind of strength of character that exemplifies a life of integrity.”

Published by Christian Faith Publishing, Ronald R. Strahl’s new book is an attempt to explore the strength of the meek through a second story involving the resident of a hidden forest and the humans that interact with them.

Through this book, Strahl takes the readers to an exciting reading experience as the book shows how the characters display the kind of strength that elucidates a life of integrity.

View a synopsis of “Inheritance of the Meek: The Return to Hidden Forest” on YouTube.

Consumers can purchase “Inheritance of the Meek: The Return to Hidden Forest” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Inheritance of the Meek: The Return to Hidden Forest,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Business: Executives

Good Leads® Announces the “Strong Start 2020” Incentive Plan for Outsourced B2B Lead Generation Services

Leave a comment


News Image

Good Leads CEO Bob Good

The goal is to quickly fill our client’s sales pipeline in the winter/spring such that they get an early start on their 2020 revenue goals, stated CEO Bob Good


SALEM, N.H. (PRWEB)

Good Leads® announces the “Strong Start 2020″ incentive plan with a focus on Q1 of 2020 that provides a 2 month pilot term offering for outsourced business development services. Good Leads will rapidly deploy a Strategic Strike inside sales team under their Prospect Builder® Program. The fast start offering features a delayed payment option to assist SMB’s with cash management.

Using a proven process and knowledge of a client company, the Good Leads Strategic Strike Team will skillfully act as their inside sales team. Key features of the Strong Start incentive plan are customization of an ideal prospect contact database; rapid deployment of seasoned outbound calling business development professionals; short term 2 month pilot program commitment that is scalable and extendable and a financial incentive of a delayed payment option on new programs.

The Good Leads “Strong Start 2020” incentive plan is also applicable to their Sales Builder® Program and Event Builder™ Program, respectively, to drive winter sales or event attendance. And in all cases, the plan is backed by Good Leads’ signature guarantee and warranty to further protect and maximize client’s marketing and sales investment.

Good Leads CEO Bob Good stated, “Many companies are uncertain as to how to deal with the many marketing spend options. In announcing the Good Leads ‘Strong Start 2020’ plan, we are creating an incentive for our technology clients to start the year with a pipeline of opportunities by offering a quick deployment of skilled business development resources. The goal is to quickly fill our client’s sales pipeline in the winter/spring such that they get an early start on their 2020 revenue goals.”

About Good Leads:

Good Leads is a leading provider of outsourced business development services including qualified B2B lead generation, setting phone, face to face and web demo appointments specializing in enterprise software, healthcare IT, network security and product design & engineering software and design services. For 17 years, Good Leads has partnered with 450 domestic and international institutions, from high-tech to governmental agencies, to develop and implement a business development strategy as part of their integrated marketing plan. http://www.GoodLeads.com; 866 894-LEAD

Share article on social media or email:

Science: Biology

Improved Pharma now offers the detection of small amounts of amorphous material in crystalline samples

Leave a comment


News Image

Overall, due to techniques developed in-house and also by our collaborators, Improved Pharma’s problem-solving capabilities now extend to determining the amount of amorphous materials in crystalline materials


WEST LAFAYETTE, Ind. (PRWEB)

Detecting a small amount of a crystalline component in a predominantly amorphous material is relatively straight-forward, but the reverse situation can be quite daunting. Over the years, several methodologies have been developed to address this challenge. Below, Improved Pharma describes some of these approaches and announces advances of their own and also that of one of their primary collaborators, Excelsus Structure Solutions. 

In several of the early SSCI courses on Pharmaceutical Solids, the late David Grant advanced the microcalorimetric method for analyzing the amorphous content of crystalline samples. This method required that the amorphous material crystallized with a detectable energy response. This method is still utilized today and is described in USP 696. With the advent of powerful Synchrotron X-ray powder diffraction (S-XRPD) methods, several new approaches for analysis for amorphous material in a crystalline phase have been developed.

Three methods are of particular interest: (1) Methods based on pattern analysis that typically use software for spectral pattern analysis, (2) PDF-based methods, and (3) controlled measurements of S-XRPD data. The spectral pattern analysis method utilizes standard patterns of the crystalline and amorphous phases collected on a Synchrotron. This software-based approach fits the crystalline and amorphous standards to the observed data and calculates a percentage amorphous material. The PDF method has been advanced by our collaborators, Excelsus Structure Solutions. Excelsus has recently demonstrated that it was possible to perform quantitative phase analysis on a mixture of poorly- and non-crystalline excipients via conventional S-XRPD and pair distribution function analysis, provided that the experimental setup, data collection and analysis strategy were carefully optimized. A third method, optimized at Improved Pharma, involves collecting Synchrotron X-ray diffraction data under certain controlled conditions, and then performing mathematical techniques on the data to provide the reliable detection of amorphous materials. Currently, this approach is qualitative in nature, allowing for the ranking of multiple samples for their relative amorphous content. Improved Pharma is further developing the technique to provide quantitative information.

A fourth method utilizing the publicly available program AMORPH has been utilized for inorganic samples. AMORPH utilizes a new Bayesian statistical approach to interpreting X-ray diffraction results of samples with both crystalline and amorphous components (see Rowe and Brewer in Computers and Geosciences). AMORPH fits X-ray diffraction patterns with a mixture of narrow and wide components, simultaneously inferring all of the model parameters and quantifying their uncertainties. Unfortunately, to date, this program has not been utilized for drugs or organic materials.

Overall, due to techniques developed in-house and also by our collaborators, Improved Pharma’s problem-solving capabilities now extend to determining the amount of amorphous materials in crystalline materials. Contact us for problems involving crystalline and amorphous materials.

About Improved Pharma

Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Dr. Stephen Byrn and Sarah Byrn founded the company in 2006 after the successful acquisition of their first company, SSCI. Dr. Pamela Smith joined the company in 2018 after an 18-year tenure with SSCI. Improved Pharma offers services such as analytical testing, synchrotron-based formulation design, and expert consulting aiding the development and defense of intellectual property matters.

Share article on social media or email:

Society: Christianity

Dr. Sam Peebles’s newly released “First Do No Harm” is a riveting retelling of a doctor’s dealings with a man pinned as a criminal

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“First Do No Harm”: an engrossing book of the author’s circumstances as a professional medical practitioner that led him to an encounter with a gunman. “First Do No Harm” is the creation of published author Dr. Sam Peebles, a full-time emergency physician, a Bible class teacher, and a lead singer.

Dr. Peebles shares, “Dr. Sam Peebles has tried to abide by the principle of ‘First, Do No Harm’ in his medical practice and his life. On November 23, 2003, traveling home from the funeral of his nephew, they stopped to help a stranded motorist. His name is Scott Eizember. He had been the subject of an extensive manhunt in Oklahoma where he had killed two people and severely injured two others. He abducted the couple at gunpoint and forced them to drive deep into Texas. Dr. Peebles relays the events of this encounter but also talks about his faith and his family.”

Published by Christian Faith Publishing, Dr. Sam Peebles’s new book is an immersive and truthful account that shows the dedication of physicians in upholding their oath to protect life at all costs.

This book is an exemplary proof of humanity present in conflict that trained individuals can tap into to change lives toward betterment and wellness.

View the synopsis of “First Do No Harm” on YouTube.

Consumers can purchase “First Do No Harm” at traditional brick-and-mortar bookstores or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “First Do No Harm,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Health: Mental Health

Linda Wendlandt’s newly released “I Know They Say I’m Mental” is an honest expression of pieces that revolve around the struggle in one’s mental state.

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“I Know They Say I’m Mental: A Personal Perspective on Borderline Personality Disorder”: a touching memoir woven in pieces of poetry that express emotions of losing hope, finding it, and trusting in it. “I Know They Say I’m Mental: A Personal Perspective on Borderline Personality Disorder” is the creation of published author Linda Wendlandt, a surgical nurse. She practiced in the operating room as a registered nurse for some twenty-five years, during which she experienced a suicide attempt and seventeen years of professional counseling. She and her husband raised two wonderful and healthy children even through years of mental and emotional pains.

Wendlandt shares, “Have you ever tried to explain yourself and had others simply just not get it or, worse, tell you that you are just plain crazy? That was what my life was indeed like due to Borderline Personality Disorder. But I am here to say that the faulty thinking process associated with this mental illness can be overridden and that it is indeed possible to learn how to effectively communicate with others. Through psychoanalysis, medication, and self-discovery of the inner personal negative belief system, the resultant concurrent, depression can be managed and somewhat discarded for healthier ways of interacting with the outside world. It took me approximately seventeen years of therapy to be able to come to this conclusion, and I would just like the other BPDs to understand and believe that this can also happen for them.”

Published by Christian Faith Publishing, Linda Wendlandt’s new book is a stirring revelation from a woman whose mental illness brought her struggles and pains. In here, the readers will find a captivating story that will touch their hearts deeply.

View a synopsis of “I Know They Say I’m Mental: A Personal Perspective on Borderline Personality Disorder” on YouTube.

Consumers can purchase“I Know They Say I’m Mental: A Personal Perspective on Borderline Personality Disorder” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “I Know They Say I’m Mental: A Personal Perspective on Borderline Personality Disorder,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Business: Executives

Charlotte Based Golf Company Seeks To Position Golf As A Leader In Equal Opportunity

Leave a comment


“Along our own journey as a company, we have come to recognize that our tournaments should be inclusive to all golfers. Supporting both men and women through competition for the same opportunities,” says professional golfer, entrepreneur and Golf Interact / SwingThought Founder and CEO, Michael Rush


CHARLOTTE, N.C. (PRWEB)

SwingThought, a Golf Interact, LLC brand, announced today that in 2020 it will be hosting 25 tournaments coast to coast where men and women will be competing for the same prizes. By offering equal opportunities to both men and women golfers along their journey, SwingThought seeks to bring new golf experiences to a wider audience to benefit the game, golfers, courses, and community partners.

“Along our own journey as a company, we have come to recognize that our tournaments should be inclusive to all golfers…supporting both men and women through competition for the same opportunities,” says professional golfer, entrepreneur and Golf Interact / SwingThought Founder and CEO, Michael Rush. “The game of golf benefits from additional interest and participation and it is our job to provide unique experiences that benefit the individual and the group.”

Golfers will be competing for minimum guaranteed sponsored prizes with a first place offering of $25,000, and 40% of the field earning prizes. The forward thinking company aims to fill the gap in developmental golf, and provide reliable opportunities for all pros seeking to compete and take their game to the next level benefiting the company with engagement to its brand platform. Other features and benefits of SwingThought tournaments include:

SwingThought invests directly into players through its tournaments with guaranteed sponsored prizes which are not dependent upon field size whatsoever

Total prize funds are always at or above 100% of entry fees and return on entry (ROE) is best in class throughout the prize fund.

This coming Spring, ST Tournaments will be supported by a new cutting-edge SwingThought web platform and app offering all golfers statistic tracking, cloud-based data organization, CrowdSponsoring, a swing analyzer, and more tools to organize the golf journey

Additionally, the organization offers several different membership options for ST Players with benefits that include year end prizes for top performers, thousands of dollars in savings on entry fees, flexible registration, host-housing, priority access to paid pro-ams, and more.

SwingThought Tournament One (ST1) is scheduled for January 16 and 17 at Eagle Creek Golf Club in Orlando, FL with registration fees starting at $850. For details on how to register and additional schedule information visit http://www.swingthought.com.

SwingThought aims to be a thought-first innovation leader in golf, driven by a mission to connect people to the experience of the game. Since 2015, the company has invested over $3 million directly into players and has contributed to the development and advancement of more players to the PGA Tour system than any other developmental tournament system.

If you have any additional questions please contact Mary Ann Baber at maryann@swingthought.com or 205-239-1765.

Share article on social media or email:

Health

R3 Now Offering Complimentary Regenerative Procedure at Stem Cell Training Course

Leave a comment


best stem cell training course

Stem Cell Training Course (844) GET-STEM

With our courses, the hands on experience where each attendee also receives a procedure relates to new skills that are immediately useful in practice. We have real patients, not models or cadavers, with expert trainers showing the latest techniques for the best outcomes!


LAS VEGAS (PRWEB)

R3 Stem Cell is now offering all attendees to its regenerative training courses a free procedure, which will include either stem cells or exosome biologics. The hands on training allows providers the opportunity to receive the procedure benefits first hand, which allows for a deeper empathy with patients.

The R3 Stem Cell Training Courses routinely receive five star reviews from attendees, both for the comprehensive course along with the regenerative aesthetics courses. The training courses are very hands on, including real patients receiving real procedures with real biologics. No other course includes such a personal experience that also includes a free procedure for each attendee. The free procedure includes either stem cells or exosomes, along with PRP therapy if desired as well.

According to R3 CEO David Greene, MD, MBA, “With our courses, the hands on experience where each attendee also receives a procedure relates to new skills that are immediately useful in practice. We have real patients, not models or cadavers, with expert trainers showing the latest techniques for the best outcomes!”

Procedures that are taught include joint injections, IV procedures, intranasal and nebulizer. For aesthetics procedures, there’s hair restoration, facial rejuvenation, and sexual wellness therapies.

Added Dr. Greene, “We cater the experience to each provider’s needs. If a provider needs to focus on joint injections, they can spend their time learning from the image guided procedure area. Same thing if a provider wants to focus on aesthetics, we have courses specifically for that too!”

To learn more about the R3 regenerative training courses, visit https://stemcelltrainingcourse.org or call (844) GET-STEM.

About R3 Stem Cell: After 8 years and over 13,000 stem cell procedures in the US with a network of over 40 Centers, R3 has established itself as the nation’s leader in regenerative medicine. Along with that Network, R3 offers regenerative training courses which are hands on and highly practical with immediately useful knowledge and skills.

Share article on social media or email:

Business: Executives

Background Screening Firm Cisive Honored by CEO Today USA Awards 2019

Leave a comment


Background Screening Firm Cisive Honored by CEO Today USA Awards 2019

We are honored to be recognized by CEO Today Magazine as one of the most successful, innovative and forward-thinking companies pushing the envelope in business.


HOLTSVILLE, N.Y. (PRWEB)

Cisive, a global provider of compliance-driven human capital management and risk management solutions, has been named to CEO Today Magazine’s USA Awards 2019. The annual feature recognizes strong and innovative leadership amongst business leaders, celebrating the American CEOs who are changing the game in their respective sectors and beyond.

“Cisive’s quality of service, robust reporting, cost-effectiveness, and state-of-the-art technology sets us apart from all others in the background screening industry,” said James Owens, President and CEO at Cisive. “We are honored to be recognized by CEO Today Magazine as one of the most successful, innovative and forward-thinking companies pushing the envelope in business.”

Cisive’s core onboarding and pre-employment background screening offering provides clients with a streamlined, high-quality, and regulatory compliant solution. The company’s comprehensive services include background screening, vendor/contractor screening, executive screening, drug testing, fingerprinting, paperless onboarding, and electronic Form I-9/E-Verify solutions.

In addition to being recognized by the CEO Today USA Awards 2019, Cisive has previously been honored as one of 2019’s 50 Most Admired Companies by The Silicon Review, as well as Banking CIO’s Top 10 RegTech Solution Providers for 2019. For more information about Cisive’s suite of solutions, visit http://www.Cisive.com.

About Cisive

Cisive is a global leader in compliance-driven human capital and risk management solutions, providing onboarding and pre-employment background screening solutions to address the complex challenges and needs of large enterprises with dedicated, in-country account management teams committed to customer satisfaction. Cisive is accredited by the Professional Background Screeners Association (PBSA) and was named for the third consecutive year by HRO Today to the 2019 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers, in addition to being named Company of the Year by CIO Review. The company and its brands serve clients in financial services, transportation, telecom/media, healthcare, utilities and the home services end-markets, among others. For additional information, please visit http://www.cisive.com.

Share article on social media or email:

Health

NCPDP & Experian Health Announce 100% of the U.S. Population Has a Universal Patient Identifier, Powered by Experian Health UIM and NCPDP Standards™

Leave a comment


NCPDP Logo and Experian logo


SCOTTSDALE, Ariz. (PRWEB)

NCPDP and Experian Health announced today that every person in the U.S. population, of an estimated 328 million Americans, have been assigned a unique Universal Patient Identifier, powered by Experian Health Universal Identity Manager (UIM) and NCPDP Standards™ (the “UPI”). The UPI is a vendor- and provider-neutral solution for accurately matching and managing patient identification across the healthcare ecosystem. This accomplishment paves the way for profoundly reducing the risk of medical errors and improving patient safety.

Experian Health is a leader in identity management performing patient identity matching for organizations across the entire healthcare ecosystem. Combining Experian’s expansive data assets and innovative UIM technology along with the unique ability NCPDP brings to share the UPI throughout the healthcare ecosystem using the NCPDP Telecommunication Standard and its SCRIPT Standard, each individual in the U.S. that has received medical care or utilized a pharmacy has been processed through the solution and assigned a UPI.

“Having a single, unified and accurate view of the patient is a challenge that plagues the healthcare system, and now we have a comprehensive solution that reduces the barriers to make healthcare safer,” explained Lee Ann Stember, President & CEO of NCPDP.

How the UPI works comprising all Americans

The flow of communication happens when healthcare organizations send Experian Health patient demographic information; the system provides the organization in return with the insights and identifiers that they need to better manage patient identities and prevent duplicate records. The UPI can be attached – if the situational requirement is met – to active claims in real-time transactions and then appended by other healthcare partners, effectively improving the integrity of patient records for all ages.

The UPI is a number that is not known to the patient or provider. It is not intended to be a patient-facing number in an effort to prevent misuse of the identifier. The UPI does not collect or share any clinical claims or diagnostic information.

“The vision of Experian Health is to ensure each American is correctly identified and safely cared for by every healthcare organization they visit, which can be enabled through the power of data,” said Karly Rowe, Vice President New Product Development, Identity & Care Management Product for Experian. “We’re currently servicing retail pharmacies, hospitals, labs and vendors using a variety of services in real-time to prevent and resolve duplicates.”

Multiple benefits to providers and patients

By helping identify duplicate or incomplete patient records, and thereby vastly improving data quality, the UPI solution addresses patient safety, interoperability, business and operational challenges currently burdening the healthcare delivery system.

The UPI solution’s ability to achieve accurate record match rates for all ages also improves efficient, patient-centered care coordination, as well as population health management strategies, prescription drug monitoring programs (PDMPs), social determinants of health initiatives and more.

As patients move from healthcare provider to provider, the UPI will journey through the standards across different care settings and across state geographical boundaries — all the while continually synchronizing to ensure an accurate view of the patient.

“We are thrilled to celebrate this milestone achievement as an important step in tackling a critical patient safety issue with the right partner, technology and process – using industry standards,” said Stember. “At the same time, our next steps are in process as we move to help ensure that healthcare organizations nationwide are able to take advantage of the UPI to make healthcare safer for all Americans.”

For more information on how the UPI offering works, click here. To learn more about the Experian Health identity suite of products, visit https://www.experian.com/healthcare/products/identity-management.

About NCPDP

Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,600 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

About Experian Health

At Experian Health, we collaborate with more than 3,400 hospitals and 7,300 other healthcare organizations representing 500,000-plus providers — almost 60 percent of the market — to provide data-driven platforms to empower our clients to make smarter business decisions, boast a better bottom line and foster stronger patient relationships. Our industry-leading solutions include revenue cycle management, identity management, patient engagement and care management.

Part of Experian, the world’s leading information services company, our Experian Health business is known for its patient access heritage, advanced data insights and patent-pending Touchless Workflow™ which help providers, labs, pharmacies and other risk-bearing entities power opportunities in today’s consumer-driven healthcare environment.

Experian has 17,200 people operating across 44 countries, and every day we’re investing in new technologies, talented people and innovation to help all our clients maximize every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

For more information about Experian Health, visit http://www.experianhealth.com. Learn more about Experian at http://www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

###